Back to Search
Start Over
Use of a novel high-osmolar gadolinium chelate, gadobutrol, for percutaneous renal artery stenting in two patients with chronic renal failure
- Source :
-
International Journal of Cardiology . Jul2005, Vol. 102 Issue 2, p361-362. 2p. - Publication Year :
- 2005
-
Abstract
- Abstract: Gadolinium chelates have been recently proposed and preliminarily tested as contrast agents for diagnostic and interventional angiography in alternative to iodinated media. However, in most studies low-osmolarity agents were employed and digital subtraction was required for satisfactory images. In this article, we report for the first time in the literature two cases of successful percutaneous renal artery stenting in which gadobutrol, a high-osmolar (1 mmol/ml) gadolinium chelate, was employed as contrast agent because of chronic renal failure and substantial risk for iodinated contrast-associated nephrotoxicity. In both patients gadobutrol yielded high-quality images without digital subtraction and was well tolerated with no ensuing renal dysfunction. [Copyright &y& Elsevier]
- Subjects :
- *KIDNEY blood-vessels
*CHRONIC diseases
*INVALIDS
*MEDICAL radiography
Subjects
Details
- Language :
- English
- ISSN :
- 01675273
- Volume :
- 102
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- International Journal of Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 18091899
- Full Text :
- https://doi.org/10.1016/j.ijcard.2004.05.065